Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

NCT04939090 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

227

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Solid Neoplasm
Anorexia
Hematopoietic and Lymphoid Cell Neoplasm

Interventions

DRUG: Olanzapine
DRUG: Megestrol Acetate
OTHER: Questionnaire Administration

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]